Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiplatelet Therapy”

531 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 531 results

Not applicableStudy completedNCT01843361
What this trial is testing

Clopidogrel Response in Acute Ischemic Stroke. The Bochumer CRISP Study

Who this might be right for
Ischemic Stroke
Ruhr University of Bochum 159
Not applicableStudy completedNCT01278043
What this trial is testing

Antiplatelet Response, Interval Variability & Events in Percutaneous Coronary Intervention (ARIVE-PCI) Registry

Who this might be right for
Coronary Artery Disease
University of Chicago 101
Not applicableStudy completedNCT06876727
What this trial is testing

Efficacy and Safety of Antiplatelet Therapy After Endovascular Aortic Repair

Who this might be right for
Abdominal Aortic Aneurysms (AAA)Endovascular Aneurysm Repair (EVAR)
Samsung Medical Center 8,325
Large-scale testing (Phase 3)Study completedNCT02506140
What this trial is testing

Platelet Reactivity in Acute Non-disabling Cerebrovascular Events

Who this might be right for
StrokeIschemic Attack, Transient
Beijing Tiantan Hospital 675
Large-scale testing (Phase 3)Study completedNCT04522102
What this trial is testing

Antiplatelet Secondary Prevention International Randomised Trial After INtracerebral HaemorrhaGe (ASPIRING)-Pilot Phase

Who this might be right for
Intracerebral Hemorrhage
The George Institute for Global Health, China 80
Not applicableActive Not RecruitingNCT07597239
What this trial is testing

Thromboelastography With Platelet Mapping to Guide Antiplatelet Therapy After Lower Extremity Revascularization

Who this might be right for
ThrombosisArterial Occlusive DiseasesThromboelastography (TEG)+4 more
Massachusetts General Hospital 130
Post-approval studies (Phase 4)UnknownNCT02030054
What this trial is testing

Pharmacodynamic Comparison of Rosuvastatin Versus Atorvastatin on Platelet Reactivity in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy With New P2Y12 Inhibitors (Trial gRANADa)

Who this might be right for
Coronary Artery Disease
University of Roma La Sapienza 150
Post-approval studies (Phase 4)Active Not RecruitingNCT03947229
What this trial is testing

Comparison of CLOpidogrel Monotherapy Versus Extended Dual-antiplatelet Therapy Beyond 12 Months After Implantation of Drug-eluting StEnts in High-risk Lesions or Patients; A-CLOSE Trial

Who this might be right for
Coronary Artery DiseaseDES
Yonsei University 3,200
Post-approval studies (Phase 4)Study completedNCT03718429
What this trial is testing

Pharmacodynamic Effects of Low-dose Rivaroxaban With Antiplatelet Therapies

Who this might be right for
Coronary Artery DiseasePeripheral Arterial DiseaseAtrial Fibrillation
University of Florida 86
Not applicableStudy completedNCT04481997
What this trial is testing

Anti-thrombotic and Glucose Lowering Therapy in Diabetic Patients Undergoing PCI

Who this might be right for
Type2 Diabetes MellitusCoronary Heart Disease
Associacao para Investigacao e Desenvolvimento da Faculdade de Medicina - CETERA 1,000
Not applicableStudy completedNCT03197298
What this trial is testing

Change of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome

Who this might be right for
Acute Coronary SyndromePercutaneous Coronary InterventionDrug-Eluting Stents
Thorax Centrum Twente 2,062
Not applicableEnded earlyNCT00995514
What this trial is testing

Genotype Guided Comparison of Clopidogrel and Prasugrel Outcomes Study

Who this might be right for
Cardiovascular Disease
Medco Health Solutions, Inc. 4,471
Not applicableLooking for participantsNCT05566301
What this trial is testing

Multicentric Study on Clopidogrel Resistance in DAPT for CAS (MULTI-RESCLOSA)

Who this might be right for
Clopidogrel, Poor Metabolism ofCarotid Stenosis
IRCCS Policlinico S. Donato 1,140
Post-approval studies (Phase 4)UnknownNCT03908593
What this trial is testing

Proton Pump Inhibitor Preventing Upper Gastrointestinal Injury In Patients On Dual Antiplatelet Therapy After CABG

Who this might be right for
Gastrointestinal Ulcer (Peptic) or ErosionAnti-Platelet TherapyCoronary Artery Bypass
Ruijin Hospital 232
Large-scale testing (Phase 3)Looking for participantsNCT05997693
What this trial is testing

One-Month DAPT in CABG Patients

Who this might be right for
Chronic Coronary Disease
Weill Medical College of Cornell University 700
Large-scale testing (Phase 3)Looking for participantsNCT06653348
What this trial is testing

Ticagrelor Based De-Escalation of Dual Antiplatelet Therapy in Ischemic Stroke

Who this might be right for
Ischemic StrokeTransient Ischemic Attack
Mazandaran University of Medical Sciences 100
Not applicableUnknownNCT05058469
What this trial is testing

Tracheotomy With and Without Dual Antiplatelet Therapy

Who this might be right for
Tracheostomy Hemorrhage
Asklepios Neurological Clinic Bad Salzhausen 300
Post-approval studies (Phase 4)UnknownNCT05116995
What this trial is testing

Differential EFfects of Dual antIplatelet and Dual aNtithrombotic thErapy on Hemostasis in Chronic Coronary Syndrome Patients

Who this might be right for
ThrombosisMyocardial Infarction
Nova Scotia Health Authority 30
Not applicableUnknownNCT04630288
What this trial is testing

Safety and Efficacy of Ticagrelor vs Clopidogrel in Patients With Acute Coronary Syndrome

Who this might be right for
Acute Coronary Syndromes
Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud 1,900
Not applicableStudy completedNCT03218787
What this trial is testing

XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.

Who this might be right for
Coronary Artery Lesions
Abbott Medical Devices 2,047
Load More Results